Form 4: Omada Health CEO Sells Shares
Insider Transaction (Form 4)
Sean P. Duffy, Chief Executive Officer and a Director of Omada Health, Inc., sold 21,572 shares of common stock on September 1, 2026.
Summary
- Option exercise/conversion: acquired 12,944 Common Stock at $5.82 ($75,334) on September 1, 2026; holds 424,805 after (Direct).
- Option exercise/conversion: acquired 4,314 Common Stock at $8.28 ($35,720) on September 1, 2026; holds 429,119 after (Direct).
- Option exercise/conversion: acquired 4,314 Common Stock at $9.18 ($39,603) on September 1, 2026; holds 433,433 after (Direct).
- Open-market sale: disposed of 7,344 Common Stock at $23.12 ($169,782) on September 1, 2026; holds 426,089 after (Direct).
- Open-market sale: disposed of 5,600 Common Stock at $24.27 ($135,901) on September 1, 2026; holds 420,489 after (Direct).
- Open-market sale: disposed of 4,933 Common Stock at $23.13 ($114,100) on September 1, 2026; holds 415,556 after (Direct).
- Open-market sale: disposed of 3,695 Common Stock at $24.27 ($89,682) on September 1, 2026; holds 411,861 after (Direct).
- Tax/exercise-price withholding: disposed of 9,885 Common Stock at $22.84 ($225,773) on September 1, 2026; holds 401,976 after (Direct).
- Option exercise/conversion: disposed of 12,944 Stock Option (Right to Buy) on September 1, 2026; holds 129,539 after (Direct).
- Option exercise/conversion: disposed of 4,314 Stock Option (Right to Buy) on September 1, 2026; holds 106,218 after (Direct).
- Option exercise/conversion: disposed of 4,314 Stock Option (Right to Buy) on September 1, 2026; holds 512,994 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $509,465 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Sean P. Duffy — Director, Officer (Chief Executive Officer)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-01 | Option exercise/conversion | Common Stock | 12,944 | $6 | $75.3K | 424,805 |
| 2026-09-01 | Option exercise/conversion | Common Stock | 4,314 | $8 | $35.7K | 429,119 |
| 2026-09-01 | Option exercise/conversion | Common Stock | 4,314 | $9 | $39.6K | 433,433 |
| 2026-09-01 | Open-market sale | Common Stock | 7,344 | $23 | $169.8K | 426,089 |
| 2026-09-01 | Open-market sale | Common Stock | 5,600 | $24 | $135.9K | 420,489 |
| 2026-09-01 | Open-market sale | Common Stock | 4,933 | $23 | $114.1K | 415,556 |
| 2026-09-01 | Open-market sale | Common Stock | 3,695 | $24 | $89.7K | 411,861 |
| 2026-09-01 | Tax/exercise-price withholding | Common Stock | 9,885 | $23 | $225.8K | 401,976 |
| 2026-09-01 | Option exercise/conversion | Stock Option (Right to Buy) | 12,944 | — | — | 129,539 |
| 2026-09-01 | Option exercise/conversion | Stock Option (Right to Buy) | 4,314 | — | — | 106,218 |
| 2026-09-01 | Option exercise/conversion | Stock Option (Right to Buy) | 4,314 | — | — | 512,994 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-01 | Option exercise/conversion (12,944 shares) |
| 2026-09-01 | Option exercise/conversion (4,314 shares) |
| 2026-09-01 | Option exercise/conversion (4,314 shares) |
| 2026-09-01 | Open-market sale (7,344 shares) |
| 2026-09-01 | Open-market sale (5,600 shares) |
| 2026-09-01 | Open-market sale (4,933 shares) |
| 2026-09-01 | Open-market sale (3,695 shares) |
| 2026-09-01 | Tax/exercise-price withholding (9,885 shares) |
| 2026-09-01 | Option exercise/conversion (12,944 shares) |
| 2026-09-01 | Option exercise/conversion (4,314 shares) |
| 2026-09-01 | Option exercise/conversion (4,314 shares) |
Keywords
insider transaction, Form 4, OMDA, Omada Health, Inc., bearish, Sean P. Duffy
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.